Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays
April 30 2019 - 08:00AM
Business Wire
Use of Agilent’s custom microarrays in the SOMAscan® assay will
help drive biomarker discovery efforts as well as novel diagnostics
and accelerated pharmaceutical development
Agilent Technologies, Inc. (NYSE: A) and SomaLogic, Inc. (a
privately held biotechnology company) today announced a multi-year
supply agreement whereby Agilent will supply customized
high-fidelity oligo microarrays for use in the nucleic acid
detection step within SomaLogic’s novel SOMAscan assay, a protein
measurement platform with applications across basic and clinical
research, diagnostics, and pharmaceutical discovery and
development.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190430005105/en/
SomaLogic’s SOMAscan assay solves a protein measurement
challenge using a DNA measurement solution, enabling the accurate
measurement of an individual’s protein makeup with unequalled
sensitivity and dynamic range. The customized Agilent microarray,
which is based on SomaLogic’s specifications, is incorporated into
the SOMAscan assay which is used to detect and measure 5,000
proteins accurately and reproducibly from a small volume of
biological sample.
“Agilent and SomaLogic have developed a mutually rewarding
partnership over the years, and we are pleased that they will
continue to leverage our microarray platform as they scale up their
business,” said Sam Raha, president of Agilent’s Diagnostics and
Genomics Group. “Agilent’s microarray platform has demonstrated
superiority for measurement of DNA and RNA at scale and it is
exciting to see how SomaLogic is creatively applying this
capability to measure thousands of proteins in a single assay.”
“To date we have analyzed over 300,000 human samples as we have
built the SOMAscan platform,” said Roy Smythe, CEO of SomaLogic.
“Agilent custom microarrays have been a critical part of our
success to date, and as we now move into health, wellness and
disease-monitoring applications for our technology they continue to
be an extremely high quality and scalable solution.”
Specific details of the agreement were not disclosed.
About SomaLogic
SomaLogic seeks to deliver meaningful and actionable
health-management insights that empower individuals worldwide to
continuously optimize their personal health and wellness throughout
their lives. These essential insights, to be provided through a
global network of partners and users, are derived from the precise,
proprietary, and personalized measurement of critical changes in an
individual’s proteins over time. For more information, visit
www.somalogic.com and follow @somalogic on Twitter.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics and applied chemical markets. With more than
50 years of insight and innovation, Agilent instruments, software,
services, solutions, and people provide trusted answers to
customers' most challenging questions. The company generated
revenues of $4.91 billion in fiscal 2018 and employs 15,300 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
our Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190430005105/en/
Naomi GoumilloutAgilent Technologies,
Inc.+1.781.266.2819naomi.goumillout@agilent.comorLaura S. Mizoue,
Ph.D.SomaLogic, Inc.+1.720.417.7509lmizoue@somalogic.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Feb 2024 to Mar 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2023 to Mar 2024